nodes	percent_of_prediction	percent_of_DWPC	metapath
Brompheniramine—CYP2D6—breast cancer	0.0957	0.538	CbGaD
Brompheniramine—CYP3A4—breast cancer	0.0821	0.462	CbGaD
Brompheniramine—Doxylamine—Toremifene—breast cancer	0.0546	0.14	CrCrCtD
Brompheniramine—Bromodiphenhydramine—Toremifene—breast cancer	0.0462	0.119	CrCrCtD
Brompheniramine—Clofedanol—Toremifene—breast cancer	0.0375	0.0963	CrCrCtD
Brompheniramine—Orphenadrine—Toremifene—breast cancer	0.0363	0.0932	CrCrCtD
Brompheniramine—Doxylamine—Tamoxifen—breast cancer	0.0343	0.0881	CrCrCtD
Brompheniramine—Diphenhydramine—Toremifene—breast cancer	0.0322	0.0828	CrCrCtD
Brompheniramine—Tripelennamine—Tamoxifen—breast cancer	0.031	0.0797	CrCrCtD
Brompheniramine—Bromodiphenhydramine—Tamoxifen—breast cancer	0.029	0.0745	CrCrCtD
Brompheniramine—CYP2B6—Thiotepa—breast cancer	0.0258	0.0732	CbGbCtD
Brompheniramine—Clofedanol—Tamoxifen—breast cancer	0.0235	0.0605	CrCrCtD
Brompheniramine—Orphenadrine—Tamoxifen—breast cancer	0.0228	0.0585	CrCrCtD
Brompheniramine—Promazine—Tamoxifen—breast cancer	0.0217	0.0559	CrCrCtD
Brompheniramine—Diphenhydramine—Tamoxifen—breast cancer	0.0202	0.052	CrCrCtD
Brompheniramine—CYP2C9—Anastrozole—breast cancer	0.018	0.051	CbGbCtD
Brompheniramine—CYP2B6—Raloxifene—breast cancer	0.0172	0.0488	CbGbCtD
Brompheniramine—CYP2C8—Lapatinib—breast cancer	0.0172	0.0488	CbGbCtD
Brompheniramine—CYP2C19—Lapatinib—breast cancer	0.0145	0.0409	CbGbCtD
Brompheniramine—CYP3A4—Exemestane—breast cancer	0.0138	0.0391	CbGbCtD
Brompheniramine—CYP2C9—Idarubicin—breast cancer	0.0137	0.0387	CbGbCtD
Brompheniramine—CYP2C8—Raloxifene—breast cancer	0.0131	0.037	CbGbCtD
Brompheniramine—CYP2D6—Idarubicin—breast cancer	0.0125	0.0354	CbGbCtD
Brompheniramine—CYP3A4—Letrozole—breast cancer	0.0118	0.0333	CbGbCtD
Brompheniramine—CYP2E1—Tamoxifen—breast cancer	0.0116	0.0327	CbGbCtD
Brompheniramine—CYP2B6—Tamoxifen—breast cancer	0.0114	0.0323	CbGbCtD
Brompheniramine—CYP2E1—Mitoxantrone—breast cancer	0.0113	0.0319	CbGbCtD
Brompheniramine—CYP3A4—Anastrozole—breast cancer	0.0105	0.0297	CbGbCtD
Brompheniramine—CYP3A4—Toremifene—breast cancer	0.00958	0.0271	CbGbCtD
Brompheniramine—CYP3A4—Fulvestrant—breast cancer	0.00891	0.0252	CbGbCtD
Brompheniramine—CYP2B6—Irinotecan—breast cancer	0.00875	0.0248	CbGbCtD
Brompheniramine—CYP2C8—Tamoxifen—breast cancer	0.00863	0.0244	CbGbCtD
Brompheniramine—CYP3A4—Thiotepa—breast cancer	0.00794	0.0225	CbGbCtD
Brompheniramine—CYP2C9—Capecitabine—breast cancer	0.00748	0.0212	CbGbCtD
Brompheniramine—CYP3A4—Ixabepilone—breast cancer	0.00726	0.0206	CbGbCtD
Brompheniramine—CYP2C19—Tamoxifen—breast cancer	0.00724	0.0205	CbGbCtD
Brompheniramine—CYP3A4—Lapatinib—breast cancer	0.00699	0.0198	CbGbCtD
Brompheniramine—CYP2C8—Paclitaxel—breast cancer	0.00672	0.019	CbGbCtD
Brompheniramine—CYP2C8—Fluorouracil—breast cancer	0.00636	0.018	CbGbCtD
Brompheniramine—CYP2D6—Vinorelbine—breast cancer	0.0061	0.0173	CbGbCtD
Brompheniramine—CYP2C9—Tamoxifen—breast cancer	0.00602	0.017	CbGbCtD
Brompheniramine—CYP2D6—Tamoxifen—breast cancer	0.0055	0.0156	CbGbCtD
Brompheniramine—CYP3A4—Raloxifene—breast cancer	0.0053	0.015	CbGbCtD
Brompheniramine—CYP2B6—Doxorubicin—breast cancer	0.00478	0.0135	CbGbCtD
Brompheniramine—CYP2C9—Paclitaxel—breast cancer	0.00469	0.0133	CbGbCtD
Brompheniramine—CYP2C9—Fluorouracil—breast cancer	0.00444	0.0126	CbGbCtD
Brompheniramine—CYP3A4—Vinorelbine—breast cancer	0.00388	0.011	CbGbCtD
Brompheniramine—CYP2D6—Vinblastine—breast cancer	0.00376	0.0106	CbGbCtD
Brompheniramine—CYP3A4—Tamoxifen—breast cancer	0.0035	0.00991	CbGbCtD
Brompheniramine—CYP3A4—Mitoxantrone—breast cancer	0.00341	0.00967	CbGbCtD
Brompheniramine—CYP3A4—Paclitaxel—breast cancer	0.00272	0.00771	CbGbCtD
Brompheniramine—CYP3A4—Irinotecan—breast cancer	0.00269	0.00761	CbGbCtD
Brompheniramine—CHRM3—muscle of abdomen—breast cancer	0.00242	0.202	CbGeAlD
Brompheniramine—CYP3A4—Vinblastine—breast cancer	0.00239	0.00677	CbGbCtD
Brompheniramine—CYP2D6—Doxorubicin—breast cancer	0.00231	0.00654	CbGbCtD
Brompheniramine—CYP3A4—Docetaxel—breast cancer	0.00197	0.00558	CbGbCtD
Brompheniramine—CYP3A4—Doxorubicin—breast cancer	0.00147	0.00416	CbGbCtD
Brompheniramine—CHRM5—epithelium—breast cancer	0.000515	0.0429	CbGeAlD
Brompheniramine—CHRM5—skin of body—breast cancer	0.00049	0.0408	CbGeAlD
Brompheniramine—CYP2C8—mammary gland—breast cancer	0.000419	0.035	CbGeAlD
Brompheniramine—KCNH2—nipple—breast cancer	0.000379	0.0316	CbGeAlD
Brompheniramine—CYP2C9—mammary gland—breast cancer	0.000372	0.0311	CbGeAlD
Brompheniramine—HRH1—nipple—breast cancer	0.000304	0.0253	CbGeAlD
Brompheniramine—CHRM1—female reproductive system—breast cancer	0.000239	0.0199	CbGeAlD
Brompheniramine—CHRM3—adipose tissue—breast cancer	0.000233	0.0194	CbGeAlD
Brompheniramine—KCNH2—endometrium—breast cancer	0.000229	0.0191	CbGeAlD
Brompheniramine—CHRM2—endocrine gland—breast cancer	0.000222	0.0185	CbGeAlD
Brompheniramine—CHRM3—female reproductive system—breast cancer	0.000214	0.0178	CbGeAlD
Brompheniramine—KCNH2—uterus—breast cancer	0.000211	0.0176	CbGeAlD
Brompheniramine—CYP2C8—endometrium—breast cancer	0.000209	0.0175	CbGeAlD
Brompheniramine—KCNH2—pituitary gland—breast cancer	0.000207	0.0173	CbGeAlD
Brompheniramine—HRH1—epithelium—breast cancer	0.000205	0.0171	CbGeAlD
Brompheniramine—CHRM1—endocrine gland—breast cancer	0.000202	0.0169	CbGeAlD
Brompheniramine—CYP2B6—skin of body—breast cancer	0.000199	0.0166	CbGeAlD
Brompheniramine—CHRM3—female gonad—breast cancer	0.000195	0.0162	CbGeAlD
Brompheniramine—KCNH2—female reproductive system—breast cancer	0.00019	0.0158	CbGeAlD
Brompheniramine—CYP2C8—pituitary gland—breast cancer	0.000189	0.0158	CbGeAlD
Brompheniramine—KCNH2—adrenal gland—breast cancer	0.000185	0.0154	CbGeAlD
Brompheniramine—HRH1—endometrium—breast cancer	0.000183	0.0153	CbGeAlD
Brompheniramine—CHRM3—endocrine gland—breast cancer	0.000181	0.0151	CbGeAlD
Brompheniramine—KCNH2—bone marrow—breast cancer	0.000179	0.0149	CbGeAlD
Brompheniramine—CYP2C8—female reproductive system—breast cancer	0.000173	0.0145	CbGeAlD
Brompheniramine—KCNH2—female gonad—breast cancer	0.000173	0.0144	CbGeAlD
Brompheniramine—CYP2C19—endocrine gland—breast cancer	0.000168	0.014	CbGeAlD
Brompheniramine—HRH1—adipose tissue—breast cancer	0.000165	0.0138	CbGeAlD
Brompheniramine—KCNH2—endocrine gland—breast cancer	0.00016	0.0134	CbGeAlD
Brompheniramine—CYP2B6—female reproductive system—breast cancer	0.000156	0.013	CbGeAlD
Brompheniramine—CYP2C9—female reproductive system—breast cancer	0.000154	0.0128	CbGeAlD
Brompheniramine—HRH1—female reproductive system—breast cancer	0.000152	0.0127	CbGeAlD
Brompheniramine—CYP2B6—adrenal gland—breast cancer	0.000152	0.0127	CbGeAlD
Brompheniramine—HRH1—adrenal gland—breast cancer	0.000148	0.0124	CbGeAlD
Brompheniramine—CYP2C8—endocrine gland—breast cancer	0.000147	0.0122	CbGeAlD
Brompheniramine—CYP2E1—female reproductive system—breast cancer	0.000146	0.0122	CbGeAlD
Brompheniramine—CYP2E1—adrenal gland—breast cancer	0.000143	0.0119	CbGeAlD
Brompheniramine—Orphenadrine—SCN10A—breast cancer	0.000139	0.139	CrCbGaD
Brompheniramine—HRH1—female gonad—breast cancer	0.000138	0.0115	CbGeAlD
Brompheniramine—CYP2B6—endocrine gland—breast cancer	0.000132	0.011	CbGeAlD
Brompheniramine—CYP2C9—endocrine gland—breast cancer	0.00013	0.0109	CbGeAlD
Brompheniramine—HRH1—endocrine gland—breast cancer	0.000129	0.0107	CbGeAlD
Brompheniramine—Mepyramine—CYP2D6—breast cancer	0.000124	0.124	CrCbGaD
Brompheniramine—CYP2E1—endocrine gland—breast cancer	0.000124	0.0103	CbGeAlD
Brompheniramine—CYP3A4—female reproductive system—breast cancer	0.000117	0.0098	CbGeAlD
Brompheniramine—CYP2D6—female reproductive system—breast cancer	0.000116	0.00964	CbGeAlD
Brompheniramine—Tripelennamine—CYP2D6—breast cancer	0.000115	0.115	CrCbGaD
Brompheniramine—KCNH2—lymph node—breast cancer	0.000111	0.00925	CbGeAlD
Brompheniramine—CYP2D6—female gonad—breast cancer	0.000105	0.00877	CbGeAlD
Brompheniramine—CYP3A4—endocrine gland—breast cancer	9.94e-05	0.00829	CbGeAlD
Brompheniramine—CYP2D6—endocrine gland—breast cancer	9.78e-05	0.00816	CbGeAlD
Brompheniramine—Tolterodine—CYP2D6—breast cancer	9.15e-05	0.0915	CrCbGaD
Brompheniramine—HRH1—lymph node—breast cancer	8.89e-05	0.00741	CbGeAlD
Brompheniramine—Carbinoxamine—CYP2D6—breast cancer	7.85e-05	0.0785	CrCbGaD
Brompheniramine—Tolterodine—CYP3A4—breast cancer	7.85e-05	0.0785	CrCbGaD
Brompheniramine—Carbinoxamine—CYP3A4—breast cancer	6.73e-05	0.0673	CrCbGaD
Brompheniramine—Chlorphenamine—CYP2D6—breast cancer	6.67e-05	0.0667	CrCbGaD
Brompheniramine—Diphenhydramine—PTGS1—breast cancer	6.65e-05	0.0665	CrCbGaD
Brompheniramine—Chlorphenamine—CYP3A4—breast cancer	5.72e-05	0.0573	CrCbGaD
Brompheniramine—Diphenhydramine—CYP2D6—breast cancer	4.53e-05	0.0453	CrCbGaD
Brompheniramine—Orphenadrine—CYP3A4—breast cancer	3.67e-05	0.0367	CrCbGaD
Brompheniramine—Promazine—CYP3A4—breast cancer	3.35e-05	0.0335	CrCbGaD
Brompheniramine—CYP3A4—Metabolism—SLC5A5—breast cancer	1.86e-06	2.78e-05	CbGpPWpGaD
Brompheniramine—CYP2C9—Metabolism—MTHFR—breast cancer	1.85e-06	2.76e-05	CbGpPWpGaD
Brompheniramine—CHRM5—Signaling Pathways—STAT3—breast cancer	1.85e-06	2.76e-05	CbGpPWpGaD
Brompheniramine—CHRM4—Signaling Pathways—MAPK3—breast cancer	1.84e-06	2.75e-05	CbGpPWpGaD
Brompheniramine—CYP2E1—Metabolism—NOS3—breast cancer	1.83e-06	2.74e-05	CbGpPWpGaD
Brompheniramine—HRH1—Signaling Pathways—NOS3—breast cancer	1.83e-06	2.73e-05	CbGpPWpGaD
Brompheniramine—CHRM1—Signaling Pathways—NOS3—breast cancer	1.82e-06	2.72e-05	CbGpPWpGaD
Brompheniramine—CHRM3—Signaling Pathways—NOS3—breast cancer	1.82e-06	2.72e-05	CbGpPWpGaD
Brompheniramine—CHRM2—Signaling Pathways—NOS3—breast cancer	1.8e-06	2.69e-05	CbGpPWpGaD
Brompheniramine—CYP3A4—Metabolism—SLC2A1—breast cancer	1.8e-06	2.69e-05	CbGpPWpGaD
Brompheniramine—CYP3A4—Metabolism—NQO1—breast cancer	1.8e-06	2.69e-05	CbGpPWpGaD
Brompheniramine—CHRM4—Signaling Pathways—MYC—breast cancer	1.79e-06	2.68e-05	CbGpPWpGaD
Brompheniramine—CHRM4—Signaling Pathways—TGFB1—breast cancer	1.79e-06	2.67e-05	CbGpPWpGaD
Brompheniramine—CYP2C19—Metabolism of lipids and lipoproteins—PIK3CA—breast cancer	1.78e-06	2.67e-05	CbGpPWpGaD
Brompheniramine—CHRM5—Signaling Pathways—MAPK3—breast cancer	1.76e-06	2.64e-05	CbGpPWpGaD
Brompheniramine—CHRM4—Signaling Pathways—EGFR—breast cancer	1.75e-06	2.62e-05	CbGpPWpGaD
Brompheniramine—HRH1—Signaling by GPCR—PIK3CA—breast cancer	1.74e-06	2.6e-05	CbGpPWpGaD
Brompheniramine—CHRM1—Signaling by GPCR—PIK3CA—breast cancer	1.74e-06	2.59e-05	CbGpPWpGaD
Brompheniramine—HRH1—Signaling Pathways—MDM2—breast cancer	1.73e-06	2.59e-05	CbGpPWpGaD
Brompheniramine—CHRM3—Metabolism—PTEN—breast cancer	1.73e-06	2.59e-05	CbGpPWpGaD
Brompheniramine—CHRM3—Signaling by GPCR—PIK3CA—breast cancer	1.73e-06	2.59e-05	CbGpPWpGaD
Brompheniramine—CHRM1—Signaling Pathways—MDM2—breast cancer	1.73e-06	2.58e-05	CbGpPWpGaD
Brompheniramine—HRH1—Signaling Pathways—RAF1—breast cancer	1.73e-06	2.58e-05	CbGpPWpGaD
Brompheniramine—CYP2B6—Metabolism—PIK3CB—breast cancer	1.72e-06	2.58e-05	CbGpPWpGaD
Brompheniramine—CYP3A4—Metabolism—CYP1B1—breast cancer	1.72e-06	2.58e-05	CbGpPWpGaD
Brompheniramine—CHRM3—Signaling Pathways—MDM2—breast cancer	1.72e-06	2.58e-05	CbGpPWpGaD
Brompheniramine—CHRM1—Signaling Pathways—RAF1—breast cancer	1.72e-06	2.58e-05	CbGpPWpGaD
Brompheniramine—HRH1—Signaling Pathways—RELA—breast cancer	1.72e-06	2.57e-05	CbGpPWpGaD
Brompheniramine—CYP2D6—Metabolism—CAV1—breast cancer	1.72e-06	2.57e-05	CbGpPWpGaD
Brompheniramine—CHRM3—Signaling Pathways—RAF1—breast cancer	1.72e-06	2.57e-05	CbGpPWpGaD
Brompheniramine—CHRM5—Signaling Pathways—MYC—breast cancer	1.72e-06	2.56e-05	CbGpPWpGaD
Brompheniramine—CHRM1—Signaling Pathways—RELA—breast cancer	1.71e-06	2.56e-05	CbGpPWpGaD
Brompheniramine—CHRM2—Signaling by GPCR—PIK3CA—breast cancer	1.71e-06	2.56e-05	CbGpPWpGaD
Brompheniramine—CHRM5—Signaling Pathways—TGFB1—breast cancer	1.71e-06	2.56e-05	CbGpPWpGaD
Brompheniramine—HRH1—Signaling Pathways—ERBB2—breast cancer	1.71e-06	2.56e-05	CbGpPWpGaD
Brompheniramine—CHRM3—Signaling Pathways—RELA—breast cancer	1.71e-06	2.56e-05	CbGpPWpGaD
Brompheniramine—CYP2B6—Metabolism—PTGS2—breast cancer	1.71e-06	2.56e-05	CbGpPWpGaD
Brompheniramine—CHRM2—Signaling Pathways—MDM2—breast cancer	1.71e-06	2.55e-05	CbGpPWpGaD
Brompheniramine—CHRM1—Signaling Pathways—ERBB2—breast cancer	1.7e-06	2.55e-05	CbGpPWpGaD
Brompheniramine—CYP2C9—Metabolism—CAV1—breast cancer	1.7e-06	2.55e-05	CbGpPWpGaD
Brompheniramine—CYP2C19—Metabolism—PIK3CG—breast cancer	1.7e-06	2.54e-05	CbGpPWpGaD
Brompheniramine—CHRM2—Signaling Pathways—RAF1—breast cancer	1.7e-06	2.54e-05	CbGpPWpGaD
Brompheniramine—CHRM3—Signaling Pathways—ERBB2—breast cancer	1.7e-06	2.54e-05	CbGpPWpGaD
Brompheniramine—CHRM2—Signaling Pathways—RELA—breast cancer	1.69e-06	2.53e-05	CbGpPWpGaD
Brompheniramine—CYP3A4—Metabolism—HSP90AA1—breast cancer	1.69e-06	2.53e-05	CbGpPWpGaD
Brompheniramine—CYP2E1—Metabolism—PIK3CB—breast cancer	1.69e-06	2.53e-05	CbGpPWpGaD
Brompheniramine—HRH1—Signaling Pathways—MTOR—breast cancer	1.69e-06	2.52e-05	CbGpPWpGaD
Brompheniramine—HRH1—Signaling Pathways—PIK3CB—breast cancer	1.69e-06	2.52e-05	CbGpPWpGaD
Brompheniramine—CHRM2—Signaling Pathways—ERBB2—breast cancer	1.68e-06	2.52e-05	CbGpPWpGaD
Brompheniramine—CHRM1—Signaling Pathways—PIK3CB—breast cancer	1.68e-06	2.51e-05	CbGpPWpGaD
Brompheniramine—CHRM1—Signaling Pathways—MTOR—breast cancer	1.68e-06	2.51e-05	CbGpPWpGaD
Brompheniramine—CHRM5—Signaling Pathways—EGFR—breast cancer	1.68e-06	2.51e-05	CbGpPWpGaD
Brompheniramine—CHRM3—Signaling Pathways—MTOR—breast cancer	1.68e-06	2.51e-05	CbGpPWpGaD
Brompheniramine—CHRM3—Signaling Pathways—PIK3CB—breast cancer	1.68e-06	2.51e-05	CbGpPWpGaD
Brompheniramine—CYP2C8—Metabolism—PIK3CD—breast cancer	1.68e-06	2.5e-05	CbGpPWpGaD
Brompheniramine—CYP2E1—Metabolism—PTGS2—breast cancer	1.67e-06	2.5e-05	CbGpPWpGaD
Brompheniramine—CHRM2—Signaling Pathways—PIK3CB—breast cancer	1.66e-06	2.48e-05	CbGpPWpGaD
Brompheniramine—CHRM2—Signaling Pathways—MTOR—breast cancer	1.66e-06	2.48e-05	CbGpPWpGaD
Brompheniramine—CHRM4—Signaling Pathways—KRAS—breast cancer	1.66e-06	2.47e-05	CbGpPWpGaD
Brompheniramine—CYP2C8—Metabolism—ALB—breast cancer	1.65e-06	2.47e-05	CbGpPWpGaD
Brompheniramine—CYP3A4—Metabolism—NCOA1—breast cancer	1.64e-06	2.46e-05	CbGpPWpGaD
Brompheniramine—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CA—breast cancer	1.63e-06	2.43e-05	CbGpPWpGaD
Brompheniramine—HRH1—Signaling Pathways—CXCL8—breast cancer	1.62e-06	2.42e-05	CbGpPWpGaD
Brompheniramine—CYP3A4—Metabolism—STK11—breast cancer	1.62e-06	2.42e-05	CbGpPWpGaD
Brompheniramine—CYP3A4—Metabolism—CYP19A1—breast cancer	1.62e-06	2.42e-05	CbGpPWpGaD
Brompheniramine—CHRM1—Signaling Pathways—CXCL8—breast cancer	1.62e-06	2.42e-05	CbGpPWpGaD
Brompheniramine—CHRM3—Signaling Pathways—CXCL8—breast cancer	1.61e-06	2.41e-05	CbGpPWpGaD
Brompheniramine—HRH1—Signaling by GPCR—HRAS—breast cancer	1.61e-06	2.41e-05	CbGpPWpGaD
Brompheniramine—CHRM1—Signaling by GPCR—HRAS—breast cancer	1.61e-06	2.4e-05	CbGpPWpGaD
Brompheniramine—CHRM3—Signaling by GPCR—HRAS—breast cancer	1.6e-06	2.39e-05	CbGpPWpGaD
Brompheniramine—CHRM2—Signaling Pathways—CXCL8—breast cancer	1.6e-06	2.39e-05	CbGpPWpGaD
Brompheniramine—CHRM2—Signaling by GPCR—HRAS—breast cancer	1.59e-06	2.37e-05	CbGpPWpGaD
Brompheniramine—CHRM5—Signaling Pathways—KRAS—breast cancer	1.58e-06	2.37e-05	CbGpPWpGaD
Brompheniramine—HRH1—Signaling Pathways—CDKN1B—breast cancer	1.58e-06	2.37e-05	CbGpPWpGaD
Brompheniramine—CYP2C8—Metabolism—NOS3—breast cancer	1.58e-06	2.37e-05	CbGpPWpGaD
Brompheniramine—CHRM1—Signaling Pathways—CDKN1B—breast cancer	1.58e-06	2.36e-05	CbGpPWpGaD
Brompheniramine—CHRM3—Signaling Pathways—CDKN1B—breast cancer	1.57e-06	2.35e-05	CbGpPWpGaD
Brompheniramine—HRH1—GPCR downstream signaling—AKT1—breast cancer	1.57e-06	2.34e-05	CbGpPWpGaD
Brompheniramine—CYP2D6—Metabolism—PIK3CG—breast cancer	1.56e-06	2.34e-05	CbGpPWpGaD
Brompheniramine—CHRM1—GPCR downstream signaling—AKT1—breast cancer	1.56e-06	2.33e-05	CbGpPWpGaD
Brompheniramine—CHRM2—Signaling Pathways—CDKN1B—breast cancer	1.56e-06	2.33e-05	CbGpPWpGaD
Brompheniramine—CHRM3—GPCR downstream signaling—AKT1—breast cancer	1.56e-06	2.33e-05	CbGpPWpGaD
Brompheniramine—HRH1—Signaling Pathways—CASP3—breast cancer	1.55e-06	2.32e-05	CbGpPWpGaD
Brompheniramine—CYP2C9—Metabolism—PIK3CG—breast cancer	1.55e-06	2.32e-05	CbGpPWpGaD
Brompheniramine—HRH1—Signaling Pathways—IL2—breast cancer	1.55e-06	2.32e-05	CbGpPWpGaD
Brompheniramine—CHRM1—Signaling Pathways—CASP3—breast cancer	1.55e-06	2.31e-05	CbGpPWpGaD
Brompheniramine—CHRM1—Signaling Pathways—IL2—breast cancer	1.54e-06	2.31e-05	CbGpPWpGaD
Brompheniramine—CHRM3—Signaling Pathways—CASP3—breast cancer	1.54e-06	2.31e-05	CbGpPWpGaD
Brompheniramine—HRH1—Signaling by GPCR—IL6—breast cancer	1.54e-06	2.31e-05	CbGpPWpGaD
Brompheniramine—CHRM2—GPCR downstream signaling—AKT1—breast cancer	1.54e-06	2.3e-05	CbGpPWpGaD
Brompheniramine—CHRM3—Signaling Pathways—IL2—breast cancer	1.54e-06	2.3e-05	CbGpPWpGaD
Brompheniramine—CHRM1—Signaling by GPCR—IL6—breast cancer	1.54e-06	2.3e-05	CbGpPWpGaD
Brompheniramine—CHRM3—Signaling by GPCR—IL6—breast cancer	1.53e-06	2.29e-05	CbGpPWpGaD
Brompheniramine—CHRM2—Signaling Pathways—CASP3—breast cancer	1.53e-06	2.28e-05	CbGpPWpGaD
Brompheniramine—CHRM2—Signaling Pathways—IL2—breast cancer	1.52e-06	2.28e-05	CbGpPWpGaD
Brompheniramine—CHRM4—Signaling Pathways—PIK3CA—breast cancer	1.52e-06	2.27e-05	CbGpPWpGaD
Brompheniramine—CHRM2—Signaling by GPCR—IL6—breast cancer	1.52e-06	2.27e-05	CbGpPWpGaD
Brompheniramine—HRH1—Signaling Pathways—CCND1—breast cancer	1.51e-06	2.26e-05	CbGpPWpGaD
Brompheniramine—HRH1—Signaling Pathways—JUN—breast cancer	1.51e-06	2.25e-05	CbGpPWpGaD
Brompheniramine—CYP3A4—Metabolism—COMT—breast cancer	1.51e-06	2.25e-05	CbGpPWpGaD
Brompheniramine—CHRM1—Signaling Pathways—CCND1—breast cancer	1.51e-06	2.25e-05	CbGpPWpGaD
Brompheniramine—CHRM1—Signaling Pathways—JUN—breast cancer	1.5e-06	2.25e-05	CbGpPWpGaD
Brompheniramine—CHRM3—Signaling Pathways—CCND1—breast cancer	1.5e-06	2.24e-05	CbGpPWpGaD
Brompheniramine—CYP3A4—Metabolism—GSTP1—breast cancer	1.5e-06	2.24e-05	CbGpPWpGaD
Brompheniramine—CHRM3—Signaling Pathways—JUN—breast cancer	1.5e-06	2.24e-05	CbGpPWpGaD
Brompheniramine—HRH1—Signaling Pathways—CTNNB1—breast cancer	1.5e-06	2.24e-05	CbGpPWpGaD
Brompheniramine—CYP2C19—Metabolism—PIK3CD—breast cancer	1.5e-06	2.24e-05	CbGpPWpGaD
Brompheniramine—CHRM1—Signaling Pathways—CTNNB1—breast cancer	1.49e-06	2.23e-05	CbGpPWpGaD
Brompheniramine—CYP2B6—Metabolism—PTEN—breast cancer	1.49e-06	2.23e-05	CbGpPWpGaD
Brompheniramine—CHRM2—Signaling Pathways—CCND1—breast cancer	1.49e-06	2.22e-05	CbGpPWpGaD
Brompheniramine—CHRM3—Signaling Pathways—CTNNB1—breast cancer	1.49e-06	2.22e-05	CbGpPWpGaD
Brompheniramine—CHRM2—Signaling Pathways—JUN—breast cancer	1.48e-06	2.22e-05	CbGpPWpGaD
Brompheniramine—CYP3A4—Metabolism—HMOX1—breast cancer	1.48e-06	2.21e-05	CbGpPWpGaD
Brompheniramine—CYP2C19—Metabolism—ALB—breast cancer	1.48e-06	2.21e-05	CbGpPWpGaD
Brompheniramine—CYP3A4—Metabolism—ITPR1—breast cancer	1.48e-06	2.21e-05	CbGpPWpGaD
Brompheniramine—CHRM2—Signaling Pathways—CTNNB1—breast cancer	1.47e-06	2.2e-05	CbGpPWpGaD
Brompheniramine—CHRM4—Signaling Pathways—TP53—breast cancer	1.47e-06	2.2e-05	CbGpPWpGaD
Brompheniramine—HRH1—Signaling Pathways—MMP9—breast cancer	1.47e-06	2.19e-05	CbGpPWpGaD
Brompheniramine—CHRM1—Signaling Pathways—MMP9—breast cancer	1.46e-06	2.19e-05	CbGpPWpGaD
Brompheniramine—HRH1—Signaling Pathways—CDKN1A—breast cancer	1.46e-06	2.18e-05	CbGpPWpGaD
Brompheniramine—CYP2C8—Metabolism—PIK3CB—breast cancer	1.46e-06	2.18e-05	CbGpPWpGaD
Brompheniramine—CYP2E1—Metabolism—PTEN—breast cancer	1.46e-06	2.18e-05	CbGpPWpGaD
Brompheniramine—HRH1—Signaling Pathways—PTEN—breast cancer	1.46e-06	2.18e-05	CbGpPWpGaD
Brompheniramine—CHRM3—Signaling Pathways—MMP9—breast cancer	1.46e-06	2.18e-05	CbGpPWpGaD
Brompheniramine—CHRM1—Signaling Pathways—CDKN1A—breast cancer	1.46e-06	2.18e-05	CbGpPWpGaD
Brompheniramine—CHRM5—Signaling Pathways—PIK3CA—breast cancer	1.46e-06	2.18e-05	CbGpPWpGaD
Brompheniramine—CHRM1—Signaling Pathways—PTEN—breast cancer	1.45e-06	2.17e-05	CbGpPWpGaD
Brompheniramine—CHRM3—Signaling Pathways—CDKN1A—breast cancer	1.45e-06	2.17e-05	CbGpPWpGaD
Brompheniramine—CHRM3—Signaling Pathways—PTEN—breast cancer	1.45e-06	2.17e-05	CbGpPWpGaD
Brompheniramine—CYP2C8—Metabolism—PTGS2—breast cancer	1.45e-06	2.16e-05	CbGpPWpGaD
Brompheniramine—CHRM2—Signaling Pathways—MMP9—breast cancer	1.44e-06	2.16e-05	CbGpPWpGaD
Brompheniramine—CHRM2—Signaling Pathways—CDKN1A—breast cancer	1.44e-06	2.15e-05	CbGpPWpGaD
Brompheniramine—CHRM2—Signaling Pathways—PTEN—breast cancer	1.43e-06	2.14e-05	CbGpPWpGaD
Brompheniramine—HRH1—Signaling Pathways—MAPK8—breast cancer	1.43e-06	2.13e-05	CbGpPWpGaD
Brompheniramine—HRH1—Signaling by GPCR—AKT1—breast cancer	1.42e-06	2.13e-05	CbGpPWpGaD
Brompheniramine—CHRM1—Signaling Pathways—MAPK8—breast cancer	1.42e-06	2.13e-05	CbGpPWpGaD
Brompheniramine—CYP3A4—Metabolism—ABCB1—breast cancer	1.42e-06	2.12e-05	CbGpPWpGaD
Brompheniramine—CHRM1—Signaling by GPCR—AKT1—breast cancer	1.42e-06	2.12e-05	CbGpPWpGaD
Brompheniramine—CHRM3—Signaling Pathways—MAPK8—breast cancer	1.42e-06	2.12e-05	CbGpPWpGaD
Brompheniramine—CHRM3—Signaling by GPCR—AKT1—breast cancer	1.41e-06	2.11e-05	CbGpPWpGaD
Brompheniramine—CYP2C19—Metabolism—NOS3—breast cancer	1.41e-06	2.11e-05	CbGpPWpGaD
Brompheniramine—CHRM5—Signaling Pathways—TP53—breast cancer	1.41e-06	2.11e-05	CbGpPWpGaD
Brompheniramine—CHRM4—Signaling Pathways—HRAS—breast cancer	1.41e-06	2.1e-05	CbGpPWpGaD
Brompheniramine—CHRM2—Signaling Pathways—MAPK8—breast cancer	1.4e-06	2.1e-05	CbGpPWpGaD
Brompheniramine—CHRM2—Signaling by GPCR—AKT1—breast cancer	1.4e-06	2.09e-05	CbGpPWpGaD
Brompheniramine—CYP3A4—Metabolism—TYMS—breast cancer	1.39e-06	2.08e-05	CbGpPWpGaD
Brompheniramine—CYP3A4—Metabolism—NCOR1—breast cancer	1.38e-06	2.06e-05	CbGpPWpGaD
Brompheniramine—CYP3A4—Metabolism—PLA2G4A—breast cancer	1.38e-06	2.06e-05	CbGpPWpGaD
Brompheniramine—CYP3A4—Metabolism—GSTM1—breast cancer	1.38e-06	2.06e-05	CbGpPWpGaD
Brompheniramine—CYP2D6—Metabolism—PIK3CD—breast cancer	1.38e-06	2.06e-05	CbGpPWpGaD
Brompheniramine—CYP2C9—Metabolism—PIK3CD—breast cancer	1.36e-06	2.04e-05	CbGpPWpGaD
Brompheniramine—CYP2D6—Metabolism—ALB—breast cancer	1.36e-06	2.03e-05	CbGpPWpGaD
Brompheniramine—HRH1—Signaling Pathways—SRC—breast cancer	1.35e-06	2.02e-05	CbGpPWpGaD
Brompheniramine—CHRM1—Signaling Pathways—SRC—breast cancer	1.35e-06	2.02e-05	CbGpPWpGaD
Brompheniramine—CHRM5—Signaling Pathways—HRAS—breast cancer	1.35e-06	2.01e-05	CbGpPWpGaD
Brompheniramine—CHRM4—Signaling Pathways—IL6—breast cancer	1.35e-06	2.01e-05	CbGpPWpGaD
Brompheniramine—CYP2C9—Metabolism—ALB—breast cancer	1.35e-06	2.01e-05	CbGpPWpGaD
Brompheniramine—CHRM3—Signaling Pathways—SRC—breast cancer	1.34e-06	2.01e-05	CbGpPWpGaD
Brompheniramine—CHRM2—Signaling Pathways—SRC—breast cancer	1.33e-06	1.99e-05	CbGpPWpGaD
Brompheniramine—CYP3A4—Metabolism—GPX1—breast cancer	1.32e-06	1.97e-05	CbGpPWpGaD
Brompheniramine—HRH1—Signaling Pathways—VEGFA—breast cancer	1.32e-06	1.97e-05	CbGpPWpGaD
Brompheniramine—CHRM1—Signaling Pathways—VEGFA—breast cancer	1.31e-06	1.96e-05	CbGpPWpGaD
Brompheniramine—CHRM3—Signaling Pathways—VEGFA—breast cancer	1.31e-06	1.96e-05	CbGpPWpGaD
Brompheniramine—CYP3A4—Metabolism—CYP1A1—breast cancer	1.31e-06	1.95e-05	CbGpPWpGaD
Brompheniramine—HRH1—Signaling Pathways—STAT3—breast cancer	1.3e-06	1.95e-05	CbGpPWpGaD
Brompheniramine—CYP2C19—Metabolism—PIK3CB—breast cancer	1.3e-06	1.95e-05	CbGpPWpGaD
Brompheniramine—CHRM1—Signaling Pathways—STAT3—breast cancer	1.3e-06	1.94e-05	CbGpPWpGaD
Brompheniramine—CYP2D6—Metabolism—NOS3—breast cancer	1.3e-06	1.94e-05	CbGpPWpGaD
Brompheniramine—CHRM2—Signaling Pathways—VEGFA—breast cancer	1.3e-06	1.94e-05	CbGpPWpGaD
Brompheniramine—CHRM3—Signaling Pathways—STAT3—breast cancer	1.3e-06	1.94e-05	CbGpPWpGaD
Brompheniramine—CYP3A4—Metabolism—ERCC2—breast cancer	1.3e-06	1.94e-05	CbGpPWpGaD
Brompheniramine—CYP2C19—Metabolism—PTGS2—breast cancer	1.29e-06	1.93e-05	CbGpPWpGaD
Brompheniramine—CHRM5—Signaling Pathways—IL6—breast cancer	1.29e-06	1.93e-05	CbGpPWpGaD
Brompheniramine—CYP2C9—Metabolism—NOS3—breast cancer	1.29e-06	1.92e-05	CbGpPWpGaD
Brompheniramine—CHRM2—Signaling Pathways—STAT3—breast cancer	1.28e-06	1.92e-05	CbGpPWpGaD
Brompheniramine—CYP2C8—Metabolism—PTEN—breast cancer	1.26e-06	1.89e-05	CbGpPWpGaD
Brompheniramine—HRH1—Signaling Pathways—MAPK3—breast cancer	1.25e-06	1.86e-05	CbGpPWpGaD
Brompheniramine—CHRM4—Signaling Pathways—AKT1—breast cancer	1.24e-06	1.86e-05	CbGpPWpGaD
Brompheniramine—CHRM1—Signaling Pathways—MAPK3—breast cancer	1.24e-06	1.86e-05	CbGpPWpGaD
Brompheniramine—CHRM3—Signaling Pathways—MAPK3—breast cancer	1.24e-06	1.85e-05	CbGpPWpGaD
Brompheniramine—CHRM2—Signaling Pathways—MAPK3—breast cancer	1.23e-06	1.83e-05	CbGpPWpGaD
Brompheniramine—CHRM3—Metabolism—PIK3CA—breast cancer	1.22e-06	1.83e-05	CbGpPWpGaD
Brompheniramine—CYP3A4—Metabolism—MTHFR—breast cancer	1.22e-06	1.82e-05	CbGpPWpGaD
Brompheniramine—HRH1—Signaling Pathways—MYC—breast cancer	1.21e-06	1.81e-05	CbGpPWpGaD
Brompheniramine—HRH1—Signaling Pathways—TGFB1—breast cancer	1.21e-06	1.81e-05	CbGpPWpGaD
Brompheniramine—CHRM1—Signaling Pathways—MYC—breast cancer	1.21e-06	1.81e-05	CbGpPWpGaD
Brompheniramine—CHRM1—Signaling Pathways—TGFB1—breast cancer	1.2e-06	1.8e-05	CbGpPWpGaD
Brompheniramine—CHRM3—Signaling Pathways—MYC—breast cancer	1.2e-06	1.8e-05	CbGpPWpGaD
Brompheniramine—CHRM3—Signaling Pathways—TGFB1—breast cancer	1.2e-06	1.8e-05	CbGpPWpGaD
Brompheniramine—CYP2D6—Metabolism—PIK3CB—breast cancer	1.2e-06	1.79e-05	CbGpPWpGaD
Brompheniramine—CHRM2—Signaling Pathways—MYC—breast cancer	1.19e-06	1.78e-05	CbGpPWpGaD
Brompheniramine—CHRM5—Signaling Pathways—AKT1—breast cancer	1.19e-06	1.78e-05	CbGpPWpGaD
Brompheniramine—CHRM2—Signaling Pathways—TGFB1—breast cancer	1.19e-06	1.78e-05	CbGpPWpGaD
Brompheniramine—CYP2C9—Metabolism—PIK3CB—breast cancer	1.19e-06	1.78e-05	CbGpPWpGaD
Brompheniramine—CYP2D6—Metabolism—PTGS2—breast cancer	1.19e-06	1.78e-05	CbGpPWpGaD
Brompheniramine—HRH1—Signaling Pathways—EGFR—breast cancer	1.19e-06	1.77e-05	CbGpPWpGaD
Brompheniramine—CHRM1—Signaling Pathways—EGFR—breast cancer	1.18e-06	1.77e-05	CbGpPWpGaD
Brompheniramine—CYP2C9—Metabolism—PTGS2—breast cancer	1.18e-06	1.76e-05	CbGpPWpGaD
Brompheniramine—CHRM3—Signaling Pathways—EGFR—breast cancer	1.18e-06	1.76e-05	CbGpPWpGaD
Brompheniramine—CHRM2—Signaling Pathways—EGFR—breast cancer	1.17e-06	1.74e-05	CbGpPWpGaD
Brompheniramine—CYP2C19—Metabolism—PTEN—breast cancer	1.13e-06	1.68e-05	CbGpPWpGaD
Brompheniramine—CYP3A4—Metabolism—CAV1—breast cancer	1.12e-06	1.68e-05	CbGpPWpGaD
Brompheniramine—HRH1—Signaling Pathways—KRAS—breast cancer	1.12e-06	1.67e-05	CbGpPWpGaD
Brompheniramine—CHRM1—Signaling Pathways—KRAS—breast cancer	1.12e-06	1.67e-05	CbGpPWpGaD
Brompheniramine—CHRM3—Signaling Pathways—KRAS—breast cancer	1.11e-06	1.66e-05	CbGpPWpGaD
Brompheniramine—CHRM2—Signaling Pathways—KRAS—breast cancer	1.1e-06	1.65e-05	CbGpPWpGaD
Brompheniramine—CYP2B6—Metabolism—PIK3CA—breast cancer	1.05e-06	1.57e-05	CbGpPWpGaD
Brompheniramine—CYP2D6—Metabolism—PTEN—breast cancer	1.04e-06	1.55e-05	CbGpPWpGaD
Brompheniramine—CYP2E1—Metabolism—PIK3CA—breast cancer	1.03e-06	1.54e-05	CbGpPWpGaD
Brompheniramine—HRH1—Signaling Pathways—PIK3CA—breast cancer	1.03e-06	1.54e-05	CbGpPWpGaD
Brompheniramine—CYP2C9—Metabolism—PTEN—breast cancer	1.03e-06	1.54e-05	CbGpPWpGaD
Brompheniramine—CHRM1—Signaling Pathways—PIK3CA—breast cancer	1.03e-06	1.53e-05	CbGpPWpGaD
Brompheniramine—CYP3A4—Metabolism—PIK3CG—breast cancer	1.02e-06	1.53e-05	CbGpPWpGaD
Brompheniramine—CHRM3—Signaling Pathways—PIK3CA—breast cancer	1.02e-06	1.53e-05	CbGpPWpGaD
Brompheniramine—CHRM2—Signaling Pathways—PIK3CA—breast cancer	1.01e-06	1.51e-05	CbGpPWpGaD
Brompheniramine—CHRM3—Metabolism—AKT1—breast cancer	9.98e-07	1.49e-05	CbGpPWpGaD
Brompheniramine—HRH1—Signaling Pathways—TP53—breast cancer	9.95e-07	1.49e-05	CbGpPWpGaD
Brompheniramine—CHRM1—Signaling Pathways—TP53—breast cancer	9.92e-07	1.48e-05	CbGpPWpGaD
Brompheniramine—CHRM3—Signaling Pathways—TP53—breast cancer	9.89e-07	1.48e-05	CbGpPWpGaD
Brompheniramine—CHRM2—Signaling Pathways—TP53—breast cancer	9.79e-07	1.46e-05	CbGpPWpGaD
Brompheniramine—HRH1—Signaling Pathways—HRAS—breast cancer	9.52e-07	1.42e-05	CbGpPWpGaD
Brompheniramine—CHRM1—Signaling Pathways—HRAS—breast cancer	9.49e-07	1.42e-05	CbGpPWpGaD
Brompheniramine—CHRM3—Signaling Pathways—HRAS—breast cancer	9.46e-07	1.41e-05	CbGpPWpGaD
Brompheniramine—CHRM2—Signaling Pathways—HRAS—breast cancer	9.36e-07	1.4e-05	CbGpPWpGaD
Brompheniramine—HRH1—Signaling Pathways—IL6—breast cancer	9.11e-07	1.36e-05	CbGpPWpGaD
Brompheniramine—CHRM1—Signaling Pathways—IL6—breast cancer	9.08e-07	1.36e-05	CbGpPWpGaD
Brompheniramine—CHRM3—Signaling Pathways—IL6—breast cancer	9.05e-07	1.35e-05	CbGpPWpGaD
Brompheniramine—CYP3A4—Metabolism—PIK3CD—breast cancer	8.99e-07	1.34e-05	CbGpPWpGaD
Brompheniramine—CHRM2—Signaling Pathways—IL6—breast cancer	8.96e-07	1.34e-05	CbGpPWpGaD
Brompheniramine—CYP2C8—Metabolism—PIK3CA—breast cancer	8.9e-07	1.33e-05	CbGpPWpGaD
Brompheniramine—CYP3A4—Metabolism—ALB—breast cancer	8.88e-07	1.33e-05	CbGpPWpGaD
Brompheniramine—CYP2B6—Metabolism—AKT1—breast cancer	8.59e-07	1.28e-05	CbGpPWpGaD
Brompheniramine—CYP3A4—Metabolism—NOS3—breast cancer	8.49e-07	1.27e-05	CbGpPWpGaD
Brompheniramine—CYP2E1—Metabolism—AKT1—breast cancer	8.41e-07	1.26e-05	CbGpPWpGaD
Brompheniramine—HRH1—Signaling Pathways—AKT1—breast cancer	8.4e-07	1.26e-05	CbGpPWpGaD
Brompheniramine—CHRM1—Signaling Pathways—AKT1—breast cancer	8.38e-07	1.25e-05	CbGpPWpGaD
Brompheniramine—CHRM3—Signaling Pathways—AKT1—breast cancer	8.35e-07	1.25e-05	CbGpPWpGaD
Brompheniramine—CHRM2—Signaling Pathways—AKT1—breast cancer	8.27e-07	1.24e-05	CbGpPWpGaD
Brompheniramine—CYP2C19—Metabolism—PIK3CA—breast cancer	7.95e-07	1.19e-05	CbGpPWpGaD
Brompheniramine—CYP3A4—Metabolism—PIK3CB—breast cancer	7.84e-07	1.17e-05	CbGpPWpGaD
Brompheniramine—CYP3A4—Metabolism—PTGS2—breast cancer	7.77e-07	1.16e-05	CbGpPWpGaD
Brompheniramine—CYP2D6—Metabolism—PIK3CA—breast cancer	7.31e-07	1.09e-05	CbGpPWpGaD
Brompheniramine—CYP2C8—Metabolism—AKT1—breast cancer	7.27e-07	1.09e-05	CbGpPWpGaD
Brompheniramine—CYP2C9—Metabolism—PIK3CA—breast cancer	7.24e-07	1.08e-05	CbGpPWpGaD
Brompheniramine—CYP3A4—Metabolism—PTEN—breast cancer	6.77e-07	1.01e-05	CbGpPWpGaD
Brompheniramine—CYP2C19—Metabolism—AKT1—breast cancer	6.49e-07	9.7e-06	CbGpPWpGaD
Brompheniramine—CYP2D6—Metabolism—AKT1—breast cancer	5.97e-07	8.93e-06	CbGpPWpGaD
Brompheniramine—CYP2C9—Metabolism—AKT1—breast cancer	5.92e-07	8.85e-06	CbGpPWpGaD
Brompheniramine—CYP3A4—Metabolism—PIK3CA—breast cancer	4.78e-07	7.14e-06	CbGpPWpGaD
Brompheniramine—CYP3A4—Metabolism—AKT1—breast cancer	3.9e-07	5.84e-06	CbGpPWpGaD
